Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among ...

Diffblue today announced the general availability of the Diffblue Testing Agent, an autonomous regression test generator that ...

Somiya Adrees is a writer at GameRant. Her gaming journey began at a young age with classics like Super Mario Bros., Sonic the Hedgehog, and Disney's Aladdin in Nasira's Revenge (all of which she ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Researchers have discovered new regions of the human genome particularly vulnerable to mutations. These altered stretches of DNA can be passed down to future generations and are important for how we ...

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...

Insurance covers some genetic tests, such as BRCA tests for breast cancer, if you meet certain requirements. Find Cheap Health Insurance Quotes in Your Area But there are about 70,000 different ...

GameSpot may get a commission from retail offers. The outdoors feels more dangerous than ever in Grounded 2, and many bug types seem eager to bully you. Completing challenges will help you earn ...

After talking about the local/CI split on logging, move details to the monitoring page. Structure between this page and dependency management. Clean up after card #533 completes. Treat your build as ...

The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...

Panelists discuss how to approach second-line therapy decisions for patients with metastatic breast cancer, emphasizing the importance of biomarker testing, including ESR1 mutations, and considering ...